Predictive Oncology Inc
POAI
Get informed when a big investor buys or sells
+ FollowMarket Cap$96.55M
Close$
$0.48
90.1% downside
Current Fair Value
90.1% downsideOvervalued by 90.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $96.55 Million |
|---|---|
| Enterprise Value | $91.03 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-13.37 |
| Beta | 1.35 |
| Outstanding Shares | 21,184,617 |
Return
| Return on Equity | -567.61% |
|---|---|
| Return on Assets | -505.46% |
| Return on Invested Capital | -583.35% |
Valuation & Multiples
| P/E Ratio | -0.06 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | 4.91 |
| Enterprise Value to Revenue | 1810.37 |
| Enterprise Value to EBIT | -0.38 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.60%▲ 0.74% |
|---|---|
| Total Invested | $550,665▼ 49.05% |
| Investors Holding | 140% |
ESG Score
No data
About Axe Compute Inc.
14 employees
CEO: Christopher Miglino Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial...